Tagawa Hiroyuki
Department of Hematology, Nephrology, and Rheumatology, Akita University Graduate School of Medicine, Akita, 0108543, Japan.
Adv Exp Med Biol. 2015;889:41-50. doi: 10.1007/978-3-319-23730-5_3.
microRNAs (miRNAs) are noncoding regulatory RNAs usually consisting of 20-24 nucleotides. During the past decade, increases and decreases in miRNA expression have been shown to associate with various types of diseases, including cancer. Over 4500 miRNAs have been identified in humans, and it is known that nearly all human protein-encoding genes can be controlled by miRNAs in both healthy and malignant cells. Detailed genome-wide miRNA expression analysis has been performed in various malignant lymphoma subtypes, and these analyses have led to the discovery of subtype-specific miRNA alterations. In this chapter, I describe several key miRNAs and their targets in distinct malignant lymphoma subsets and their roles in their pathogenesis, studies of which will lead new therapeutic strategies against aggressive lymphomas.
微小RNA(miRNA)是通常由20 - 24个核苷酸组成的非编码调节RNA。在过去十年中,miRNA表达的增加和减少已被证明与包括癌症在内的各种类型疾病相关。在人类中已鉴定出超过4500种miRNA,并且已知几乎所有人类蛋白质编码基因在健康细胞和恶性细胞中都可受到miRNA的调控。已经在各种恶性淋巴瘤亚型中进行了详细的全基因组miRNA表达分析,这些分析导致发现了亚型特异性的miRNA改变。在本章中,我描述了几种关键的miRNA及其在不同恶性淋巴瘤亚群中的靶标,以及它们在发病机制中的作用,对这些的研究将引领针对侵袭性淋巴瘤的新治疗策略。